STAT(@statnews):Three glaucoma patients have received Life Biosciences' cellular reprogramming drug, with no serious adverse events. The drug is the first human test of the theory that giving a precise cocktail of proteins could rejuvenate cells back to a younger state.

STAT

@statnews

Reporting from the frontiers of health & medicine. Sign up for any of our newsletters here:

加入 July 2015

4.7K 正在關注 165.3K 粉絲

STAT@statnews

2026.10.09 15:47

Three glaucoma patients have received Life Biosciences' cellular reprogramming drug, with no serious adverse events. The drug is the first human test of the theory that giving a precise cocktail of proteins could rejuvenate cells back to a younger state.